88 results
Page 2 of 5
8-K
EX-99.1
7940culg1byz2z
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
ujt5lvmtly34nryl41
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
klfl95g0ccklx
21 Sep 20
Other Events
7:14am
8-K
EX-99.1
8qf3e65ydur12tpk6xa
30 Jul 20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
7:17am
8-K
EX-99.1
zd5 tuw5tdnster
30 Apr 20
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations andCOVID-19 Response
7:19am
8-K
EX-99.1
1buacfg7n
13 Jan 20
Regulation FD Disclosure
4:32pm
8-K
EX-99.3
7o4rq
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-99.2
c4n3erq3 drgg3
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
8qnprd0tge z7ckfq5i
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-99.1
cdy3woh
22 Nov 19
Other Events
5:01pm
8-K
yj0c geiv99ph6g5x
22 Nov 19
Other Events
5:01pm
8-K
EX-99.1
565ij2emry6qyahlmtw
31 Oct 19
Agios Reports Business Highlights and Third Quarter 2019 Financial Results
7:39am
8-K
EX-99.1
oegeeqc004dr10x1e
30 Sep 19
Other Events
11:13am
8-K
2zq072i iwjw
30 Sep 19
Other Events
11:13am
8-K
EX-99.1
qnr4rdf7snkxrzk
1 Aug 19
Agios Reports Business Highlights and Second Quarter 2019 Financial Results
7:29am
8-K
7nml10t8xh
3 Jun 19
Other Events
4:02pm
8-K
EX-99.1
x0cy520 oc27mn
3 Jun 19
Other Events
4:02pm
8-K
EX-99.1
x9d4ks ha0jbe
15 May 19
Achieved its Primary Endpoint in Previously Treated IDH1 Mutant Cholangiocarcinoma
4:13pm
8-K
EX-99.1
fszyg8956xn3w7sr
2 May 19
Other Events
3:24pm